Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma
| Autor: | Yan Aalto, Ulla M. Saarinen-Pihkala, Sakari Knuutila, Sakari Wikström, Kim Vettenranta |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Male
Cancer Research medicine.medical_specialty Disease Biology law.invention Neuroblastoma 03 medical and health sciences 0302 clinical medicine Risk Factors law Genetics medicine Chromosomes Human Humans Stage (cooking) Risk factor Child Molecular Biology Neoplasm Staging 030304 developmental biology Chromosome Aberrations 0303 health sciences Cytogenetics Infant Nucleic Acid Hybridization Chromosome DNA Neoplasm Aneuploidy Prognosis medicine.disease Combined Modality Therapy Survival Analysis 3. Good health Treatment Outcome Child Preschool 030220 oncology & carcinogenesis Cancer research Suppressor Female Chromosome Deletion Follow-Up Studies Comparative genomic hybridization |
| Zdroj: | Cancer Genetics and Cytogenetics. 125:125-130 |
| ISSN: | 0165-4608 |
| DOI: | 10.1016/s0165-4608(00)00366-6 |
| Popis: | Aggressive neuroblastoma remains a therapeutic challenge, and additional understanding of its biology is of paramount importance. Changes in DNA-copy number were analysed in the neuroblastoma cells of 27 patients using comparative genomic hybridization (CGH). Eighteen of the patients had a poor risk disease (16/18 stage IV) and 9 had a non-poor-risk disease (3/9 stage I–II, 2/9 stage III, and 4/9 stage IVS). Changes in DNA-copy number were detected in 72% of the poor-risk and 22% of the non-poor-risk tumors with gains of chromosomal material being more prevalent than losses. Gains were most common in chromosomes 2, 7, and 17 and losses in chromosome 11. Changes in DNA-copy number were multiple in all but one of the patients with poor-risk disease. The applicability of CGH in studies on the genomic changes in pediatric malignancies is demonstrated by our data also adding weight to the argument of multiple elements with oncogenic and/or tumor suppressor potential being involved in the aggressive phenotype of poor-risk neuroblastoma. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect